ES439690A1 - Procedure for preparing quinazoline derivatives. (Machine-translation by Google Translate, not legally binding) - Google Patents
Procedure for preparing quinazoline derivatives. (Machine-translation by Google Translate, not legally binding)Info
- Publication number
- ES439690A1 ES439690A1 ES439690A ES439690A ES439690A1 ES 439690 A1 ES439690 A1 ES 439690A1 ES 439690 A ES439690 A ES 439690A ES 439690 A ES439690 A ES 439690A ES 439690 A1 ES439690 A1 ES 439690A1
- Authority
- ES
- Spain
- Prior art keywords
- group
- formula
- see formula
- aryl
- hydrogen atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Procedure for preparing quinazoline derivatives, of formula: **(See formula)** wherein (i) R1 is a hydrogen atom or a lower alkyl group; (R2) n represents 1 to 3 optional substituents, each R being a hydrogen atom or a lower hydroxy or alkoxy group and a being 1 to 3, or any two of the B2 moieties constituting a methylenedioxy or ethylenedioxy group attached to positions adjacent to ring A; (ii) X represents -CH2) p where p is 1 to 3, -CH = CH- or -0CH2 CH = CH (iii) Y is attached to position 3 or 4 of ring C and represents: (a) a group of formula -Z1-COR3, where Z1 is -CH2-or (see formula), R3 is a lower alkyl group optionally substituted by an amino, hydroxy, lower alkoxy, aryl or heteroaryl group; a lower alkenyl- or lower alkynyl-methyl group; a lower alkoxy group optionally substituted by an amino, aryl, heteroaryl, lower alkoxy or hydroxy group; an aryl group; an aryloxy group; or a heteroaryl group; and R4 is a hydrogen atom; a lower alkyl group optionally substituted by an amino, lower alkoxy, hydroxy, carbotoxy, aryl or heteroaryl group; a lower alkenyl- or lower alkynyl-methyl group; an aryl group or a heteroaryl group; (b) a group of the formula: **(See formula)** wherein R5 is a group or as defined above for R3 or is a group of formula: **(See formula)** wherein R7 is a hydrogen atom or a lower alkyl group and R6 is a group as defined above for R4, or R6 and R7 taken together with the nitrogen atom to which they are attached form a saturated monocyclic heterocyclic ring; or (c) a group of the formula: **(See formula)** wherein Z2 is Z1 or -O- and R6 and R7 are defined or as above, provided that when Z2 is (see formula), R4 and R7 taken together may represent - (CH2) 2-, - (CH2) 3 - or an o-phenylene group; and (iv) R is a hydrogen atom or a lower alkyl group attached to the same carbon atom as Y; provided that when Z is -CH = CH- or -CHsCH = GH-, R is absent and Y is -CH2COR3, -CH2CON (R6) (R7) or -CH2CSN (R6) (R7) where R3, R6 and R7 are defined or as above, Y being attached to an unsaturated ring carbon atom; characterized in that it comprises reacting a quinazoline of the formula: **(See formula)** where R1, R2 and n are defined as above and Q1 is a good leaving group, such as chlorine or bromine, with an amine of formula: **(See formula)** wherein X, Y and E are defined as above, any R2 and Y groups being protected or capable of displacing the leaving group Q1, prior to the reaction and deprotected after the reaction; and then recovering the resulting compound of formula (I). (Machine-translation by Google Translate, not legally binding)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB3280574 | 1974-07-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES439690A1 true ES439690A1 (en) | 1977-07-01 |
Family
ID=10344259
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES439690A Expired ES439690A1 (en) | 1974-07-25 | 1975-07-24 | Procedure for preparing quinazoline derivatives. (Machine-translation by Google Translate, not legally binding) |
ES455984A Expired ES455984A1 (en) | 1974-07-25 | 1977-02-16 | Procedure for preparing quinazoline derivatives. (Machine-translation by Google Translate, not legally binding) |
ES455986A Expired ES455986A1 (en) | 1974-07-25 | 1977-02-16 | Procedure for preparing quinazoline derivatives. (Machine-translation by Google Translate, not legally binding) |
ES455985A Expired ES455985A1 (en) | 1974-07-25 | 1977-02-16 | Procedure for preparing quinazoline derivatives. (Machine-translation by Google Translate, not legally binding) |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES455984A Expired ES455984A1 (en) | 1974-07-25 | 1977-02-16 | Procedure for preparing quinazoline derivatives. (Machine-translation by Google Translate, not legally binding) |
ES455986A Expired ES455986A1 (en) | 1974-07-25 | 1977-02-16 | Procedure for preparing quinazoline derivatives. (Machine-translation by Google Translate, not legally binding) |
ES455985A Expired ES455985A1 (en) | 1974-07-25 | 1977-02-16 | Procedure for preparing quinazoline derivatives. (Machine-translation by Google Translate, not legally binding) |
Country Status (7)
Country | Link |
---|---|
AT (1) | AT344178B (en) |
BE (1) | BE831654A (en) |
CS (1) | CS192549B2 (en) |
ES (4) | ES439690A1 (en) |
HU (1) | HU174961B (en) |
PL (6) | PL104615B1 (en) |
SU (5) | SU578874A3 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070004763A1 (en) * | 2005-06-10 | 2007-01-04 | Nand Baindur | Aminoquinoline and aminoquinazoline kinase modulators |
-
1975
- 1975-07-08 AT AT525275A patent/AT344178B/en active
- 1975-07-18 PL PL1975193422A patent/PL104615B1/en unknown
- 1975-07-18 PL PL1975193421A patent/PL103791B1/en not_active IP Right Cessation
- 1975-07-18 PL PL1975182162A patent/PL99427B1/en unknown
- 1975-07-18 PL PL1975193423A patent/PL103797B1/en unknown
- 1975-07-18 PL PL1975193419A patent/PL103798B1/en unknown
- 1975-07-18 HU HU75PI483A patent/HU174961B/en unknown
- 1975-07-18 PL PL1975193420A patent/PL103789B1/en unknown
- 1975-07-21 CS CS755147A patent/CS192549B2/en unknown
- 1975-07-23 BE BE158540A patent/BE831654A/en not_active IP Right Cessation
- 1975-07-24 ES ES439690A patent/ES439690A1/en not_active Expired
- 1975-07-25 SU SU7502162232A patent/SU578874A3/en active
-
1976
- 1976-08-02 SU SU762386166A patent/SU858563A3/en active
- 1976-08-10 SU SU762388318A patent/SU634671A3/en active
- 1976-08-10 SU SU762388319A patent/SU613723A3/en active
- 1976-08-10 SU SU762388320A patent/SU625606A3/en active
-
1977
- 1977-02-16 ES ES455984A patent/ES455984A1/en not_active Expired
- 1977-02-16 ES ES455986A patent/ES455986A1/en not_active Expired
- 1977-02-16 ES ES455985A patent/ES455985A1/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
PL103789B1 (en) | 1979-07-31 |
AT344178B (en) | 1978-07-10 |
PL103791B1 (en) | 1979-07-31 |
PL103798B1 (en) | 1979-07-31 |
ES455985A1 (en) | 1978-06-16 |
HU174961B (en) | 1980-04-28 |
PL193423A1 (en) | 1978-04-24 |
SU613723A3 (en) | 1978-06-30 |
PL103797B1 (en) | 1979-07-31 |
PL193420A1 (en) | 1978-04-24 |
PL193422A1 (en) | 1978-06-05 |
SU858563A3 (en) | 1981-08-23 |
ES455986A1 (en) | 1978-06-01 |
SU625606A3 (en) | 1978-09-25 |
ES455984A1 (en) | 1978-06-01 |
PL99427B1 (en) | 1978-07-31 |
SU634671A3 (en) | 1978-11-25 |
BE831654A (en) | 1976-01-23 |
SU578874A3 (en) | 1977-10-30 |
CS192549B2 (en) | 1979-08-31 |
PL104615B1 (en) | 1979-08-31 |
ATA525275A (en) | 1977-11-15 |
PL193419A1 (en) | 1978-04-24 |
PL193421A1 (en) | 1978-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES435870A1 (en) | Derivatives of pyrrolidine and piperidine | |
ES413639A1 (en) | Dopamine derivatives | |
ES8801211A1 (en) | Quinolones having antihypertensive activity. | |
ES411341A1 (en) | Hererocyclic derivatives of a guanidine | |
ES439690A1 (en) | Procedure for preparing quinazoline derivatives. (Machine-translation by Google Translate, not legally binding) | |
ES448594A1 (en) | Diarylbutanolamines | |
ES423104A1 (en) | Procedure for preparing heterociclic anilides. (Machine-translation by Google Translate, not legally binding) | |
ES428400A1 (en) | Pheno aldehydes | |
ES435955A1 (en) | A procedure for obtaining a pirid derivative (3,4-d) pyridezine. (Machine-translation by Google Translate, not legally binding) | |
ES386846A1 (en) | Hydroxamic acid derivatives of alphaaminooxy carboxylic acids | |
ES466968A1 (en) | Heterocyclic nitrogen compound and process for preparing same | |
ES451292A1 (en) | A procedure for the preparation of tienotiacin derivatives. (Machine-translation by Google Translate, not legally binding) | |
ES423745A1 (en) | Procedure for preparing 2-aminoindane derivatives. (Machine-translation by Google Translate, not legally binding) | |
BG60066B2 (en) | Method for the preparation of 4--/3-/4-oxothiazolydine// butynylamine | |
ES362612A1 (en) | 3-hydrocarbon-4-tertiary amino methyl sydnones | |
ES398973A1 (en) | N-derivatives of 4-amino-4-desoxy-rifamycin sv and preparation | |
ES422085A1 (en) | Primary amino acylanilides methods of making the same and use as antiarrhythmic drugs | |
ES421262A1 (en) | A procedure for the preparation of a 2-aminoalcohil-3-fenil-indol. (Machine-translation by Google Translate, not legally binding) | |
ES426328A1 (en) | A procedure for the preparation of new derivatives of 1,2,3,4-tetrahidroisoquinoleina. (Machine-translation by Google Translate, not legally binding) | |
ES416230A1 (en) | Procedure for the preparation of a compound benzamide hete rociclico. (Machine-translation by Google Translate, not legally binding) | |
ES406345A1 (en) | Aminoalcohol derivatives | |
ES366913A1 (en) | A procedure for the preparation of therapeutically active substitute cyclohexanes. (Machine-translation by Google Translate, not legally binding) | |
ES412484A1 (en) | Procedure for the preparation of carbostirilic derivatives. (Machine-translation by Google Translate, not legally binding) | |
ES412061A1 (en) | Phenoxypropylamine derivatives and the preparation thereof | |
GB1032251A (en) | Piperazine compounds and their preparation |